Recall Register

Drug recall: 8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50 mL, Rx only, Hospira Inc, Lake…

Class I FDA enforcement event 73653. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Presence of Particulate Matter: particulate matter identified as an insect in one vial.

Class I, in the words of FDA

a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

Hospira Inc. started this drug recall on 18 Mar 2016. The firm address in the FDA record is in Lake Forest, IL. FDA put the recall in Class I. FDA event 73653 has 1 product record. The first FDA enforcement report date is 1 Jun 2016. The record gives the status Ongoing.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide

Recalling firm

Hospira Inc., Lake Forest, IL.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 73653: product records
Recall numberProductQuantityClassStatusReport date
D-0865-20168.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50 mL, Rx only, Hospira Inc, Lake Forest, IL 60045, NDC 0409-6625-0272,000 unitsClass IOngoing1 Jun 2016

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class I: The highest of the three FDA recall classes.

The event in context

Drug events that started in 2016
288
Share of these events in Class I
11%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
151

Other events of the firm

Other FDA enforcement events of Hospira Inc.
InitiatedProduct (first record)TypeClassRecords
21 Apr 2017Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, HospirDrugClass I1
1 Nov 2016Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., Lake Forest IL 6DrugClass II1
15 Aug 2016DOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV Use Only, Must be Diluted Prior to Use, (12.5 mg per mL), Rx DrugClass II1
29 Jun 20165% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia DrugClass III1
23 Jun 2016Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC 0409-1273-32DrugClass II1
6 May 2016Vancomycin Hydrochloride for Injection, USP, 10 g, 100 mL vial, Rx only, Hospira, Lake Forest, IL, NDC 0409-6510-01DrugClass II1
25 Mar 2016The Plum 360 is a large volume infuser capable of delivering fluids for a variety of therapies such as parenteral, enterDeviceClass II2
23 Mar 2016Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial, packaged in 25 vialDrugClass III1
23 Mar 2016Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial, packaged in 25 vialDrugClass I1
15 Mar 2016Quelicin (Succinylcholine Chloride) Injection, USP 200 mg. (20 mg/mL), 10 mL Multiple-dose vial, packaged in 25 Unit viaDrugClass III1

Hospira Inc.: all 151 events

Official channels

Cite this page

Recall Register. FDA enforcement event 73653. https://recallregister.com/fda/i/73653/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide
What quantity of product is in FDA event 73653?
The FDA record gives this quantity: 72,000 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2016 have the same class?
11% of the 288 drug events that started in 2016 are in Class I.